During the past decade, Yale New Haven Hospital - Investigational Drug Services conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale New Haven Hospital - Investigational Drug Services" #1 collaborator was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Yale New Haven Hospital - Investigational Drug Services" are "Alopecia Areata" (2 trials), "Alzheimer Disease" (1 trials), "Alzheimer's Disease" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Staphylococcal Vaccine" (1 trials). Many other conditions were trialed in "Yale New Haven Hospital - Investigational Drug Services" in a lesser frequency.

Most popular intervention types in "Yale New Haven Hospital - Investigational Drug Services" are "Biological" (4 trials), "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "PF-06651600" (2 trials), "ACC-001 10 μg/ QS-21 50 μg" (1 trials), "ACC-001 3 μg/ QS-21 50 μg" (1 trials) and "Meningococcal (groups A, C, W-135 and Y [ACWY]) oligosaccharide diphtheria CRM197 conjugate vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yale New Haven Hospital - Investigational Drug Services" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Yale New Haven Hospital - Investigational Drug Services". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Yale New Haven Hospital - Investigational Drug Services, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Yale New Haven Hospital - Investigational Drug Services, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".